Dr. Andreadis on CAR T-Cell Therapy for Pediatric ALL

Charalambos (Babis) Andreadis, MD, MSCE
Published: Friday, Dec 29, 2017



Charalambos (Babis) Andreadis, MD, MSCE, associate professor of clinical medicine, Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the role of chimeric antigen receptor (CAR) T-cell therapy for pediatric patients with acute lymphoblastic leukemia (ALL).

According to Andreadis, pediatric ALL is largely curable with available treatments. However, there is a subset of patients who do not do well with frontline therapy. Those patietns are now seeing responses with CAR T-cell therapy.

There are still problems with the longevity of response, explains Andreadis. It is not clear which patients will benefit from subsequent stem cell transplant versus being monitored once they respond to CAR T-cell therapy.
 


Charalambos (Babis) Andreadis, MD, MSCE, associate professor of clinical medicine, Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, discusses the role of chimeric antigen receptor (CAR) T-cell therapy for pediatric patients with acute lymphoblastic leukemia (ALL).

According to Andreadis, pediatric ALL is largely curable with available treatments. However, there is a subset of patients who do not do well with frontline therapy. Those patietns are now seeing responses with CAR T-cell therapy.

There are still problems with the longevity of response, explains Andreadis. It is not clear which patients will benefit from subsequent stem cell transplant versus being monitored once they respond to CAR T-cell therapy.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™: Choosing Therapies for Patients with EGFR-mutant Lung Cancers: More Options... More Decisions... Better OutcomesApr 27, 20182.0
Community Practice Connections™: 21st Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and MyelomaApr 27, 20182.0
Publication Bottom Border
Border Publication
x